ゼリア新薬工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/02/18 | 2,045 | 2,045 | 2,029 | 2,030 | -19 | -0.9% | 60,700 |
2025/02/17 | 2,073 | 2,073 | 2,047 | 2,049 | -18 | -0.9% | 44,000 |
2025/02/14 | 2,100 | 2,100 | 2,057 | 2,067 | -14 | -0.7% | 62,700 |
2025/02/13 | 2,085 | 2,098 | 2,071 | 2,081 | +5 | +0.2% | 51,900 |
2025/02/12 | 2,080 | 2,085 | 2,057 | 2,076 | +2 | +0.1% | 69,600 |
2025/02/10 | 2,100 | 2,102 | 2,067 | 2,074 | -22 | -1% | 132,700 |
2025/02/07 | 2,094 | 2,113 | 2,050 | 2,096 | -46 | -2.1% | 137,800 |
2025/02/06 | 2,219 | 2,223 | 2,131 | 2,142 | -7 | -0.3% | 190,100 |
2025/02/05 | 2,155 | 2,161 | 2,129 | 2,149 | +3 | +0.1% | 120,400 |
2025/02/04 | 2,186 | 2,193 | 2,140 | 2,146 | -17 | -0.8% | 76,300 |
2025/02/03 | 2,222 | 2,233 | 2,152 | 2,163 | -74 | -3.3% | 90,000 |
2025/01/31 | 2,244 | 2,244 | 2,208 | 2,237 | -3 | -0.1% | 41,000 |
2025/01/30 | 2,220 | 2,240 | 2,214 | 2,240 | +12 | +0.5% | 63,100 |
2025/01/29 | 2,267 | 2,267 | 2,222 | 2,228 | -24 | -1.1% | 37,800 |
2025/01/28 | 2,270 | 2,272 | 2,252 | 2,252 | -2 | -0.1% | 31,700 |
2025/01/27 | 2,272 | 2,272 | 2,243 | 2,254 | +5 | +0.2% | 26,100 |
2025/01/24 | 2,243 | 2,274 | 2,236 | 2,249 | +18 | +0.8% | 64,300 |
2025/01/23 | 2,246 | 2,246 | 2,208 | 2,231 | +8 | +0.4% | 77,400 |
2025/01/22 | 2,270 | 2,270 | 2,219 | 2,223 | -39 | -1.7% | 51,300 |
2025/01/21 | 2,229 | 2,262 | 2,226 | 2,262 | +43 | +1.9% | 61,500 |
2025/01/20 | 2,211 | 2,227 | 2,195 | 2,219 | +8 | +0.4% | 37,500 |
2025/01/17 | 2,202 | 2,219 | 2,172 | 2,211 | +13 | +0.6% | 67,000 |
2025/01/16 | 2,210 | 2,210 | 2,184 | 2,198 | -9 | -0.4% | 66,000 |
2025/01/15 | 2,216 | 2,220 | 2,190 | 2,207 | -18 | -0.8% | 49,300 |
2025/01/14 | 2,241 | 2,241 | 2,208 | 2,225 | -26 | -1.2% | 50,000 |
2025/01/10 | 2,257 | 2,267 | 2,245 | 2,251 | -30 | -1.3% | 32,700 |
2025/01/09 | 2,295 | 2,298 | 2,273 | 2,281 | -29 | -1.3% | 36,700 |
2025/01/08 | 2,310 | 2,318 | 2,288 | 2,310 | -3 | -0.1% | 63,200 |
2025/01/07 | 2,339 | 2,341 | 2,311 | 2,313 | -26 | -1.1% | 65,400 |
2025/01/06 | 2,433 | 2,433 | 2,330 | 2,339 | -103 | -4.2% | 89,400 |
2024/12/30 | 2,453 | 2,464 | 2,424 | 2,442 | -8 | -0.3% | 45,300 |
2024/12/27 | 2,438 | 2,450 | 2,420 | 2,450 | +40 | +1.7% | 48,100 |
2024/12/26 | 2,425 | 2,425 | 2,392 | 2,410 | +2 | +0.1% | 44,600 |
2024/12/25 | 2,450 | 2,450 | 2,387 | 2,408 | -30 | -1.2% | 34,000 |
2024/12/24 | 2,415 | 2,447 | 2,415 | 2,438 | +7 | +0.3% | 24,600 |
2024/12/23 | 2,402 | 2,440 | 2,402 | 2,431 | +25 | +1% | 34,300 |
2024/12/20 | 2,432 | 2,452 | 2,406 | 2,406 | -40 | -1.6% | 85,000 |
2024/12/19 | 2,378 | 2,455 | 2,372 | 2,446 | +39 | +1.6% | 37,200 |
2024/12/18 | 2,466 | 2,485 | 2,404 | 2,407 | -48 | -2% | 53,400 |
2024/12/17 | 2,473 | 2,505 | 2,452 | 2,455 | -12 | -0.5% | 60,400 |
2024/12/16 | 2,450 | 2,473 | 2,426 | 2,467 | +16 | +0.7% | 28,400 |
2024/12/13 | 2,400 | 2,455 | 2,400 | 2,451 | +16 | +0.7% | 66,400 |
2024/12/12 | 2,440 | 2,444 | 2,410 | 2,435 | +9 | +0.4% | 39,600 |
2024/12/11 | 2,424 | 2,443 | 2,401 | 2,426 | +2 | +0.1% | 33,800 |
2024/12/10 | 2,457 | 2,479 | 2,420 | 2,424 | -11 | -0.5% | 57,700 |
2024/12/09 | 2,405 | 2,448 | 2,395 | 2,435 | +39 | +1.6% | 87,400 |
2024/12/06 | 2,362 | 2,396 | 2,362 | 2,396 | +40 | +1.7% | 54,100 |
2024/12/05 | 2,343 | 2,364 | 2,329 | 2,356 | +13 | +0.6% | 30,500 |
2024/12/04 | 2,362 | 2,368 | 2,323 | 2,343 | -31 | -1.3% | 38,800 |
2024/12/03 | 2,330 | 2,383 | 2,315 | 2,374 | +51 | +2.2% | 58,300 |
51~
100
件表示中 / 3692件
類似銘柄と比較する
現在ご覧いただいている「ゼリア新薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ゼリア新薬 | 234,300円 | +14.2% | +41.0% | 1.96% | 11.48倍 | 1.17倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
鳥居薬 | 523,000円 | +7.1% | -35.0% | 2.29% | 43.25倍 | 1.21倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
東和薬品 | 263,700円 | +15.0% | -7.3% | 2.65% | 8.65倍 | 0.82倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
ジーエヌアイ | 241,500円 | +21.7% | +999.9% | 0.00% | 10.06倍 | 3.33倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
持田薬 | 309,000円 | +3.0% | +27.5% | 2.59% | 19.56倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
市場注目の銘柄
チャート関連のコラム